Contemplation on approved drugs in India from 1999 through 2011

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue 3, 2012, Pages 25-29

  Kataria, Bhaven C ^a   Bhavsar, Vinayak H ^b   Donga, Bhavesh N ^c  

^a CU Shah Medical College & Hospital   (India)

^b Chirayu Medical College and Hospital   (India)

^c K J Mehta General Hospital and College of Medical Sciences   (India)

Author keywords

ATC group; Drug approval; Fixed dose combination; New drug; Regulatory

Indexed keywords

AMLODIPINE; ANTIINFECTIVE AGENT; ATENOLOL; BUPIVACAINE; CINITAPRIDE; CLEBOPRIDE; ETODOLAC; EXENDIN 4; FOSAPREPITANT; GATIFLOXACIN; ILAPRAZOLE; LAFUTIDINE; METOPROLOL; ONDANSETRON; PALONOSETRON; PANTOPRAZOLE; RABEPRAZOLE; RAMOSETRON; RIMONABANT; ROFECOXIB; ROSIGLITAZONE; S ADENOSYLMETHIONINE; SAXAGLIPTIN; SIBUTRAMINE; SITAGLIPTIN; TEGASEROD; TROXIPIDE; UNINDEXED DRUG; VALDECOXIB; VOGLIBOSE;

ARTICLE; CARDIOVASCULAR SYSTEM; DIGESTIVE SYSTEM; DRUG APPROVAL; DRUG DOSAGE FORM; DRUG INDUSTRY; DRUG MANUFACTURE; DRUG QUALITY; DRUG SAFETY; HEALTH CARE NEED; HUMAN; INDIA; NERVOUS SYSTEM; PATENT;

EID: 84875418011     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Spellberg B, Powers JH, Brass EP, Miller LG, Edwards JE. Trends in antimicrobial drug development: implications for the future. Clin Infect Dis 2004; 38: 1279-86.
2. Report of the working group on drugs and pharmaceuticals for the eleventh five-year plan (2007-2012), Planning commission of India. [Internet] 2012. Available from: http: //planningcommission. nic. in/aboutus/committee/wrkgrp11/wg11_pharma. pdf [Last accessed on 2012 Feb 25].
3. The Central Drugs Standard Control Organization (CDSCO). List of drug approved for marketing in India. [Internet] 2012. Available from: http: //cdsco. nic. in/listofdrugapprovedmain. html. [Last accessed on 2012 Feb 25].
4. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment, 2012. Oslo, 2011.
5. The Central Drugs Standard Control Organization (CDSCO). Drugs banned in India. [Internet] 2012. Available from: http: //cdsco. nic. in/html/Drugsbanned. html. [Last accessed on 2012 Feb 25].
6. U. S. Food and Drug Administration. Is it true FDA is approving fewer new drugs lately? [Internet] 2012. Available from: http: //www. fda. gov/downloads/AboutFDA/Transparency/Basics/UCM247465. pdf. [Last accessed on 2012 Feb 25].
7. Ghosh A, Hazra A, Mandal SC. New drugs in India over the past 15 years: Analysis of trends. Natl Med J India 2004; 17: 10-16.
8. U. S. Food and Drug Administration. NME Drug and New Biologic Approvals. [Internet] 2012. Available from: http: //www. fda. gov/downloads/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedandApproved/DrugandBiologicApprovalReports/UCM242695. pdf. [Last accessed on 2012 Feb 25].
9. The Central Drugs Standard Control Organization (CDSCO). Mashelkar committee report. [Internet] 2012. Available from: http: //cdsco. nic. in/html/Final%20Report%20mashelkar. pdf. [Last accessed on 2012 Feb 25].
10. Government of India. Ministry of Home Affairs. Office of the Registrar General and Census Commissioner India. [Internet] 2012. Available from: http: //www. censusindia. gov. in/2011-provresults/data_files/india/Final%20PPT%202011_chapter 3. pdf. [Last accessed on 2012 Feb 25].